Adage Capital Partners Gp, L.L.C. Equillium, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Equillium, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,329,416 shares of EQ stock, worth $5.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,329,416Holding current value
$5.44 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EQ
# of Institutions
37Shares Held
22.3MCall Options Held
134KPut Options Held
0-
Adar1 Capital Management, LLC Austin, TX5.56MShares$5.67 Million0.75% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$4.54 Million1.82% of portfolio
-
Decheng Capital LLC Menlo Park, CA4.45MShares$4.54 Million1.11% of portfolio
-
Woodline Partners LP San Francisco, CA3.51MShares$3.58 Million0.03% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2MShares$2.04 Million0.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $35M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...